Meet some of the members of the Geisel School of Medicine’s Class of 2021—KC Collier, Tianrae Chu, and Allie Morgan—as they share their stories about what brought them to the Dartmouth community and why they wanted to pursue a career in medicine.
Articles by: Timothy Dean
Meet some of the members of the Geisel School of Medicine’s Class of 2021—Sand Mastrangelo, Shuaibu Ali, Sylvia Guerra, and Meredith Ryan—as they share their stories about what brought them to the Dartmouth community and why they wanted to pursue a career in medicine
A team of Geisel researchers will receive funding from the Patient-Centered Outcomes Research Institute (PCORI) to design new methods for comparing the effectiveness of alternative therapies that can lead to improvements in practice and better outcomes for patients.
Ninety-two members of the Geisel School of Medicine’s 221st class were enthusiastically welcomed to Hanover by the Dartmouth community as part of this year’s orientation for incoming medical students, which runs from August 7-11.
Morgan Gilman, a fourth-year graduate student in the McLellan Lab at Geisel, is helping lead efforts to understand how a particular type of protein allows deadly viruses—such as Ebola and RSV (respiratory syncytial virus)—to gain entry into host cells, and how antibodies can be developed to neutralize that process.
Dartmouth SYNERGY Scholars prepares young clinical scientists for success in today’s highly competitive research environment.
A team of Dartmouth researchers has found that mothers who have developed antibodies against the herpes simplex virus (HSV-1) can pass these antibodies to the nervous systems of their infants, protecting them from acquiring the virus.
A new study by researchers at Dartmouth has found that adolescents living in medical marijuana states with a plethora of dispensaries are more likely to have tried new methods of cannabis use, such as edibles and vaping, at a younger age than those living in states with fewer dispensaries.
William Wickner, MD, a professor of biochemistry and cell biology, recently received the William C. Rose Award from the American Society for Biochemistry and Molecular Biology.
Thanks to a collaboration between the pharmaceutical company MedImmune and Geisel structural biologist Jason McLellan, PhD, a long-awaited vaccine to protect infants from RSV may soon become a reality. Their findings are featured as this month’s cover story in the journal Science Translational Medicine.